176 GLP-1RAs and diseases As a rising star in recent years, GLP-1RAs are not only effective in metabolic diseases but also play a role in non-metabolic disorders, affecting multiple systems including the musculoskeletal, nervous, cardiovascular, and digestive systems, and can even have implications in oncological diseases
The gap is that pharmaceutical manufacturers are studying these drugs for many more indications, including cardiovascular disease, liver disease, kidney disease, and other conditions well beyond weight loss
Obesity 21 , 21632171 (2013)
You do not need to overhaul your entire life overnight
We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99.9% or greater